Poll results: What pipeline presbyopia treatment are you most looking forward to?

Optometry Times® polled our audience with the following question from October 22, 2021 to November 5, 2021:​ What pipeline presbyopia treatment are you most looking forward to?

The poll appeared on optometrytimes.com and was promoted on various social media channels. Results show the presbyopia treatment ODs are most looking forward to is Visus Therapeutics Brimochol.

81 ODs responded, in total. Of these:

• 1 responded "Orasis CSF-1"
• 5 responded "Allergan AGN-190584 drop"
• 3 responded "Eyenovia MicroLine drop"
• 1 responded "Presbyopia Therapies PRX-100"
• 2 responded "Ocuphire Pharma Nyxol"
• 69 responded "Visus Therapeutics Brimochol"

Click here to take our latest poll: Where are you focusing your efforts in Q4?